152 related articles for article (PubMed ID: 8830735)
1. Introduction of the interferon gamma gene into mouse T lymphoma cells with low MHC class I-expression results in selective induction of H-2Dk and concomitant enhanced metastasis.
Geldhof AB; VandenDriessche T; Opdenakker G; De Baetselier P
Cancer Immunol Immunother; 1996 Jul; 42(6):329-38. PubMed ID: 8830735
[TBL] [Abstract][Full Text] [Related]
2. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
[TBL] [Abstract][Full Text] [Related]
3. Immunogenization of a murine T-cell lymphoma via transfection with interferon-gamma.
Raes G; Geldhof A; Vanden Driessche T; Opdenakker G; Sibille C; De Baetselier P
Leukemia; 1995 Oct; 9 Suppl 1():S121-7. PubMed ID: 7475304
[TBL] [Abstract][Full Text] [Related]
4. Introduction of the H-2Dk gene into a class I-negative tumor cell line confers interferon-gamma inducibility upon the silent endogenous H-2Kk gene.
Rosenthal LA; Klyczek KK; Blank KJ
Cell Immunol; 1992 Nov; 145(1):43-55. PubMed ID: 1423645
[TBL] [Abstract][Full Text] [Related]
5. Association between MHC class I antigen expression and malignancy of murine T lymphoma variants.
Vanden Driessche T; Verschueren H; De Baetselier P
Invasion Metastasis; 1990; 10(2):65-85. PubMed ID: 2307562
[TBL] [Abstract][Full Text] [Related]
6. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
[TBL] [Abstract][Full Text] [Related]
7. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity.
Geldhof AB; Raes G; Bakkus M; Devos S; Thielemans K; De Baetselier P
Cancer Res; 1995 Jul; 55(13):2730-3. PubMed ID: 7540948
[TBL] [Abstract][Full Text] [Related]
8. NK sensitivity, H-2 expression and metastatic potential: analysis of H-2Dk gene transfected fibrosarcoma cells.
Gopas J; Rager-Zisman B; Har-Vardi I; Hammerling GJ; Bar-Eli M; Segal S
J Immunogenet; 1989; 16(4-5):305-13. PubMed ID: 2639905
[TBL] [Abstract][Full Text] [Related]
9. Multiple effects of transfection with interleukin 2 and/or interferon gamma on the behavior of mouse T lymphoma cells.
Geldhof AB; Van Ginderachter J; Vandersteen P; Raes G; De Baetselier P
Clin Exp Metastasis; 1998 Jul; 16(5):447-59. PubMed ID: 10091940
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis.
Kundu N; Fulton AM
Cell Immunol; 1997 Aug; 180(1):55-61. PubMed ID: 9316639
[TBL] [Abstract][Full Text] [Related]
11. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
[TBL] [Abstract][Full Text] [Related]
12. Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.
Lollini PL; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Cavallo F; Giovarelli M; Forni G; Modica A; Modesti A
Hum Gene Ther; 1995 Jun; 6(6):743-52. PubMed ID: 7548274
[TBL] [Abstract][Full Text] [Related]
13. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
14. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.
Lollini PL; Bosco MC; Cavallo F; De Giovanni C; Giovarelli M; Landuzzi L; Musiani P; Modesti A; Nicoletti G; Palmieri G
Int J Cancer; 1993 Sep; 55(2):320-9. PubMed ID: 8370628
[TBL] [Abstract][Full Text] [Related]
16. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.
Salcedo R; Stauffer JK; Lincoln E; Back TC; Hixon JA; Hahn C; Shafer-Weaver K; Malyguine A; Kastelein R; Wigginton JM
J Immunol; 2004 Dec; 173(12):7170-82. PubMed ID: 15585838
[TBL] [Abstract][Full Text] [Related]
17. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.
VandenDriessche T; Bakkus M; Toussaint-Demylle D; Thielemans K; Verschueren H; De Baetselier P
Clin Exp Metastasis; 1994 Jan; 12(1):73-83. PubMed ID: 8287623
[TBL] [Abstract][Full Text] [Related]
19. MHC class I up-regulation protects some but not all targets against LAK-mediated lysis: possible implications for the existence of LAK cell subpopulations using different recognition strategies.
Sarin A; Haridas V; Saxena RK
Immunol Lett; 1993 Sep; 38(1):59-62. PubMed ID: 8300155
[TBL] [Abstract][Full Text] [Related]
20. Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor.
Shiloni E; Karp SE; Custer MC; Shilyansky J; Restifo NP; Rosenberg SA; Mulé JJ
Cancer Immunol Immunother; 1993 Oct; 37(5):286-92. PubMed ID: 8402732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
